Proviva Therapeutics
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $18M
Investors
- 6
About Proviva Therapeutics
, trading under the name Proviva Therapeutics, develops cytokine-based antitumor biologics using proprietary prodrug and immune-activation platforms. The company focuses on oncology indications and provides early-stage and clinical biologic candidates, including PTX-912. It operates as a subsidiary of Viva Biotech Holdings and conducts research targeting both tumor and infectious-disease applications. The company works with pharmaceutical partners and research organizations to develop cytokine-based antitumor biologics, including the Crossover cytokine prodrug platform, the MUSICA immune-cell activation platform and candidates such as PTX-912. The company’s revenue is generated through research partnerships, licensing agreements and collaboration arrangements with pharmaceutical companies. The company plans to advance global clinical development of PTX-912, expand its preclinical biologic pipeline and continue developing cytokine-focused platforms for oncology applications.
Who invested in Proviva Therapeutics
6 investors across 2 rounds
See all investors in Proviva Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Proviva Therapeutics
Who invested in Proviva Therapeutics?
Proviva Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proviva Therapeutics raised?
Proviva Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Proviva Therapeutics last raise money?
Proviva Therapeutics's most recent round on record is a Series A, in Dec 2025.
What does Proviva Therapeutics do?
, trading under the name Proviva Therapeutics, develops cytokine-based antitumor biologics using proprietary prodrug and immune-activation platforms.
Where is Proviva Therapeutics headquartered?
Proviva Therapeutics is headquartered in Shanghai, China.
Which VCs invest in companies like Proviva Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Proviva Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Proviva Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.